Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -206,800.00%-2.07M | -455K | -102.02%-59K | 383.51%3.72M | -70.70%793.18K | 100.09%1K | 0 | 226.56%2.93M | -447.75%-1.31M | -50.59%2.71M |
| Net profit before non-cash adjustment | 181.91%557K | --686K | -44.90%1.15M | 401.90%2.08M | 132.64%679.93K | -379.84%-680K | --0 | 1,833.33%2.08M | -514.88%-688.96K | -1,244.36%-2.08M |
| Total adjustment of non-cash items | 9.68%238K | --293K | -73.50%185K | -66.17%906.23K | -100.60%-8.77K | -51.45%217K | --0 | 81.30%698K | 307.28%2.68M | 1,052.51%1.46M |
| -Depreciation and amortization | 192.61%263K | --281K | -75.63%281K | -23.15%1.15M | -18.95%284.23K | -171.54%-284K | --0 | 201.04%1.15M | 76.60%1.5M | 25.36%350.67K |
| -Reversal of impairment losses recognized in profit and loss | --0 | --1K | --0 | -565.52%-456.5K | -823.89%-456.5K | -514.29%-145K | --0 | --145K | 118.63%98.06K | 111.98%63.06K |
| -Assets reserve and write-off | ---- | ---- | ---- | -42.52%596.17K | -45.03%570.17K | ---- | ---- | ---- | 159.93%1.04M | --1.04M |
| -Share of associates | ---99K | ---13K | 81.18%-121K | ---643.41K | ---- | ---- | --0 | ---643K | --0 | ---- |
| -Disposal profit | --0 | --0 | --0 | 97.19%-1.5K | 100.94%500 | ---2K | --0 | --0 | ---53.41K | ---53.41K |
| -Other non-cash items | 452.38%74K | --24K | -41.86%25K | 167.82%258.25K | 272.47%236.25K | -240.00%-21K | --0 | 2,050.00%43K | 258.64%96.43K | 391.17%63.43K |
| Changes in working capital | -716.81%-2.86M | ---1.43M | -1,039.19%-1.39M | 122.23%734.02K | -96.33%122.02K | 125.15%464K | --0 | 105.74%148K | -639.58%-3.3M | -39.55%3.33M |
| -Change in receivables | ---- | ---- | ---- | 104.20%303.04K | ---- | ---- | ---- | ---- | -284.40%-7.21M | ---- |
| -Change in payables | ---- | ---- | ---- | -92.85%280.57K | ---- | ---- | ---- | ---- | 175.22%3.92M | ---- |
| -Changes in other current assets | -777.31%-15.58M | ---303K | 64.12%-197K | 1,110.03%150.4K | -58.40%2.48M | -23.42%-1.78M | --0 | 79.76%-549K | -473.11%-14.89K | -2.66%5.95M |
| -Changes in other current liabilities | 467.81%12.72M | ---1.13M | -271.16%-1.19M | -82.16%697K | -148.99%-2.24M | 651.72%2.24M | --0 | 416.30%697K | --3.91M | --4.57M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -452.38%-74K | -24K | 43.18%-25K | -125.19%-258.25K | -242.53%-235.25K | 240.00%21K | 0 | -193.33%-44K | -114.68K | -68.68K |
| Interest received (cash flow from operating activities) | 0 | 0 | 0 | -257.67%-191.03K | -189.16%-192.03K | 0 | 0 | -92.31%1K | -152.23%-53.41K | -278.26%-66.41K |
| Tax refund paid | -221.36%-267K | -153K | 61.03%-228K | -26.08%-615.98K | -241.17%-250.98K | 188.35%220K | 0 | -535.87%-585K | -19.62%-488.56K | 41.35%-73.56K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -1,095.04%-2.41M | ---632K | -113.58%-312K | 248.58%2.85M | -88.01%305.95K | 117.05%242K | --0 | 195.51%2.3M | -2,791.32%-1.92M | -52.89%2.55M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -211.76%-57K | ---17K | 87.42%-19K | 72.47%-110.94K | -101.79%-10.94K | 120.65%51K | --0 | 55.33%-151K | 59.11%-402.99K | 185.86%610.01K |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---587.06K | ---- |
| Net business purchase and sale | --0 | --0 | --0 | -6.87%-2.74M | 68.90%-539.21K | --0 | --0 | ---2.2M | ---2.57M | ---1.73M |
| Net investment product transactions | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 44.45%3M | --0 |
| Dividends received (cash flow from investment activities) | --0 | ---- | ---- | ---517.06K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net changes in other investments | ---- | ---- | ---- | --100K | ---- | ---- | ---- | --100K | ---- | ---- |
| Investing cash flow | -16.33%-57K | --283K | 99.16%-19K | -506.26%-3.37M | 37.62%-1.07M | 92.43%-49K | --0 | -566.86%-2.25M | -150.94%-555.91K | -140.07%-1.71M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --2.66M | ---56K | -104.42%-55K | --1.24M | ---- | ---- | --0 | --1.25M | --0 | ---- |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | --0 | --0 | -96.82%100K | ---- |
| Increase or decrease of lease financing | -206.36%-117K | ---111K | 76.92%-108K | 3.79%-467.9K | 20.56%-109.9K | 194.83%110K | --0 | -303.45%-468K | -80.35%-486.34K | -5.07%-138.34K |
| Cash dividends paid | ---- | ---- | ---- | ---618K | ---197K | ---- | ---- | ---618K | ---- | ---- |
| Cash dividends for minorities | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | 371.54%2.55M | ---363K | -202.52%-163K | 259.74%776.89K | 1,224.65%1.56M | -708.62%-938K | --0 | 237.07%159K | -116.93%-486.34K | -4.82%-138.34K |
| Net cash flow | ||||||||||
| Beginning cash position | -35.24%2.16M | -13.89%2.87M | 8.18%3.33M | -46.82%3.21M | 8.06%2.59M | -27.17%3.33M | 4.32%3.33M | -48.97%3.08M | 201.40%6.04M | 65.36%2.4M |
| Current changes in cash | 111.01%82K | ---712K | -343.35%-494K | 108.54%252.63K | 13.14%794.63K | 65.86%-745K | --0 | 107.10%203K | -173.29%-2.96M | -84.64%702.34K |
| Effect of exchange rate changes | --0 | --0 | -36.73%31K | 188.24%49K | --0 | --0 | --0 | 188.24%49K | --17K | --0 |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---129.94K | ---- | ---- | ---- | ---- | ---- | ---- |
| End cash Position | -13.44%2.24M | -35.24%2.16M | -13.89%2.87M | 8.20%3.33M | 8.20%3.33M | 8.06%2.59M | -27.17%3.33M | 4.32%3.33M | -48.97%3.08M | -48.97%3.08M |
| Free cash flow | -941.30%-2.47M | ---649K | -115.42%-331K | 192.28%2.73M | -88.41%291.92K | 117.59%293K | --0 | 178.24%2.15M | -223.80%-2.96M | -46.46%2.52M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.